Dr. Vitaliy Molchanov, MD

Dr. Molchanov practices at Martin Health Physician Group - HOPD in Port Saint Lucie, Florida.

Dr. Molchanov's NPI, 1871053249, was assigned on March 22, 2019. Dr. Molchanov holds Florida license 157059.

Dr. Molchanov's primary practice is Martin Health Physician Group - HOPD, at 10000 Sw Innovation Way, Port Saint Lucie, FL 34987.

Dr. Molchanov's primary practice is Martin Health Physician Group - HOPD in Port Saint Lucie, Florida. Dr. Molchanov is also affiliated with Cleveland Clinic Martin North Hospital. The medical group on file is Cleveland Clinic. Dmand AI also links Dr. Molchanov to 1 more group practice or clinic, named with a free account. Dr. Molchanov's employer is on file too: a hospital.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Molchanov practices, 3 sites in all. Vendor and product names are available with a free account.

Internal medicine is Dr. Molchanov's primary specialty in the NPI Registry, under taxonomy code 207R00000X. Dr. Molchanov is licensed in Florida.

CMS data shows 720 Medicare services from Dr. Molchanov across 5 procedure codes in 2024, for 304 Medicare patients. Medicare paid $52,297 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 304 Medicare patients who saw Dr. Molchanov in 2024. The largest group is 75 to 84, with 125 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 14% are also on Medicaid. Their average risk score is 2.34, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Molchanov's median patient age at 68, with 52% women.

In 2024, Dr. Molchanov wrote 354 Medicare Part D claims for 183 patients. 90% of them were for generic drugs. CMS names the drug for 111 of them, across 7 drugs with 11 or more claims each, at $455 in total drug cost. In 2023, CMS named 179 claims across 11 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 92 out of 100 for Dr. Molchanov for performance year 2024, reported through an alternative payment model (APM). Dr. Molchanov accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 29 general payments to Dr. Molchanov from 1 drug or device company from 2022 to 2024. Food and beverage make up the largest share, 100% of the total. Janssen Pharmaceuticals, Inc paid the most, $766.